{ "data": { "id": "org_dia", "slug": "dia", "name": "DIA", "short_name": "DIA", "type": "association", "tier": 2, "homepage": "https://www.diaglobal.org", "country_code": "US", "reliability_note": null, "url": "https://statorigin.org/sources/dia", "documents": [ { "title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "doc_type": "press_release", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok", "statistic_count": 20 } ], "statistics": [ { "id": "stat_9SEHGAYSGEVZP40MYK9NVXJ81A", "url": "https://statorigin.org/stat/stat_9SEHGAYSGEVZP40MYK9NVXJ81A", "indicator": { "slug": "antibody-drug-conjugate-approvals", "name": "Antibody-drug conjugate approvals", "definition": "Total number of antibody-drug conjugates granted regulatory marketing authorization." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 3, "value_text": "three", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Established Modalities Maintain a Larger Presence", "quote": "BsAbs and peptide therapies saw four new entrants each, while ADCs, cell therapies, and fusion proteins received three approvals each.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_9SEHGAYSGEVZP40MYK9NVXJ81A", "bibtex": "@misc{dia2025antibodyvxj81a,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_9SEHGAYSGEVZP40MYK9NVXJ81A},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_JM8R59GFDJR6JR50N6ESCFDKCW", "url": "https://statorigin.org/stat/stat_JM8R59GFDJR6JR50N6ESCFDKCW", "indicator": { "slug": "biologic-therapy-approvals", "name": "Biologic therapy approvals", "definition": "Total number of biological therapeutics granted regulatory marketing approval." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 40, "value_text": "40", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "quote": "These include 80 conventional medicines such as small molecules, peptides, and nucleic acids, as well as 40 biologic therapies such as monoclonal antibodies (mAbs), bispecific antibodies (BsAbs), antibody-drug conjugates (ADCs), and cell therapies.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_JM8R59GFDJR6JR50N6ESCFDKCW", "bibtex": "@misc{dia2025biologiccfdkcw,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_JM8R59GFDJR6JR50N6ESCFDKCW},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_VTRXBDTB1NEFN7JEV4E02EV9S9", "url": "https://statorigin.org/stat/stat_VTRXBDTB1NEFN7JEV4E02EV9S9", "indicator": { "slug": "bispecific-antibody-approvals", "name": "Bispecific antibody approvals", "definition": "Total number of bispecific antibody therapies authorized for commercial marketing." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 4, "value_text": "four", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Established Modalities Maintain a Larger Presence", "quote": "BsAbs and peptide therapies saw four new entrants each, while ADCs, cell therapies, and fusion proteins received three approvals each.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_VTRXBDTB1NEFN7JEV4E02EV9S9", "bibtex": "@misc{dia2025bispecific2ev9s9,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_VTRXBDTB1NEFN7JEV4E02EV9S9},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_EVH61V5CNVGR3ADB2EDGQSS2AM", "url": "https://statorigin.org/stat/stat_EVH61V5CNVGR3ADB2EDGQSS2AM", "indicator": { "slug": "breast-cancer-drug-approvals", "name": "Breast cancer drug approvals", "definition": "Number of new pharmaceutical therapies approved for breast cancer indications." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 9, "value_text": "nine", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "The Cancer Sector Continues to Attract the Most Players", "quote": "Breast cancer was the most active area with a total of nine new entrants, including the PI3Kα inhibitor inavolisib, the AKT inhibitor capivasertib, the TROP2- and HER2-targeted ADCs datopotamab deruxtecan and trastuzumab botidotin respectively, as well as multiple CDK inhibitors, namely bireociclib, lerociclib, tibremciclib, fovinaciclib, and culmerciclib.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_EVH61V5CNVGR3ADB2EDGQSS2AM", "bibtex": "@misc{dia2025breastqss2am,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_EVH61V5CNVGR3ADB2EDGQSS2AM},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_T1MJW4WJHJWYPQ2W486WCAHK5H", "url": "https://statorigin.org/stat/stat_T1MJW4WJHJWYPQ2W486WCAHK5H", "indicator": { "slug": "cell-therapy-approvals", "name": "Cell therapy approvals", "definition": "Total number of cell therapies granted regulatory marketing authorization." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 3, "value_text": "three", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Established Modalities Maintain a Larger Presence", "quote": "BsAbs and peptide therapies saw four new entrants each, while ADCs, cell therapies, and fusion proteins received three approvals each.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_T1MJW4WJHJWYPQ2W486WCAHK5H", "bibtex": "@misc{dia2025cellcahk5h,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_T1MJW4WJHJWYPQ2W486WCAHK5H},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_8V30JK5MA813ART823V6ZF2J7Y", "url": "https://statorigin.org/stat/stat_8V30JK5MA813ART823V6ZF2J7Y", "indicator": { "slug": "conventional-medicine-approvals", "name": "Conventional medicine approvals", "definition": "Total number of conventional or small molecule medicines granted regulatory marketing approval." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 80, "value_text": "80", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "quote": "These include 80 conventional medicines such as small molecules, peptides, and nucleic acids, as well as 40 biologic therapies such as monoclonal antibodies (mAbs), bispecific antibodies (BsAbs), antibody-drug conjugates (ADCs), and cell therapies.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_8V30JK5MA813ART823V6ZF2J7Y", "bibtex": "@misc{dia2025conventionalzf2j7y,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_8V30JK5MA813ART823V6ZF2J7Y},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_HX2SN17CSNNB5GG65WGM5HYS9P", "url": "https://statorigin.org/stat/stat_HX2SN17CSNNB5GG65WGM5HYS9P", "indicator": { "slug": "domestic-contribution-to-new-entrant-increase", "name": "Domestic contribution to new entrant increase", "definition": "Percentage contribution of domestic pharmaceutical developers to the net annual increase in new drug market entrants." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 81, "value_text": "81%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Domestic Players Account for Most of China’s Approvals", "quote": "In 2025, China’s innovative drug industry continued its strong development momentum and was responsible for 81% of the increase in new entrants, marking the first time that local product approvals outnumbered foreign arrivals.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_HX2SN17CSNNB5GG65WGM5HYS9P", "bibtex": "@misc{dia2025domestic5hys9p,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_HX2SN17CSNNB5GG65WGM5HYS9P},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_C33EETRSSYZ299C5SMBA9KH6MQ", "url": "https://statorigin.org/stat/stat_C33EETRSSYZ299C5SMBA9KH6MQ", "indicator": { "slug": "domestic-developer-drug-approvals", "name": "Domestic developer drug approvals", "definition": "Total number of approved new medicines originated and developed by domestic pharmaceutical enterprises." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 63, "value_text": "63", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Domestic Players Account for Most of China’s Approvals", "quote": "Among the 120 new medicines cleared by the NMPA, 63 came from domestic developers, representing 52% of the total.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_C33EETRSSYZ299C5SMBA9KH6MQ", "bibtex": "@misc{dia2025domestic9kh6mq,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_C33EETRSSYZ299C5SMBA9KH6MQ},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_403RP3RYGKCERYWB5XRN3S34KH", "url": "https://statorigin.org/stat/stat_403RP3RYGKCERYWB5XRN3S34KH", "indicator": { "slug": "domestic-developer-share-of-drug-approvals", "name": "Domestic developer share of drug approvals", "definition": "Share of total approved new medicines developed by domestic pharmaceutical companies." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 52, "value_text": "52%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Domestic Players Account for Most of China’s Approvals", "quote": "Among the 120 new medicines cleared by the NMPA, 63 came from domestic developers, representing 52% of the total.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_403RP3RYGKCERYWB5XRN3S34KH", "bibtex": "@misc{dia2025domestic3s34kh,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_403RP3RYGKCERYWB5XRN3S34KH},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_X2NWM2A19BHA2Q6D1FNAWTF9RG", "url": "https://statorigin.org/stat/stat_X2NWM2A19BHA2Q6D1FNAWTF9RG", "indicator": { "slug": "first-global-drug-approvals", "name": "First global drug approvals", "definition": "Number of new medicines obtaining their first global regulatory marketing authorization in the reporting market." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 61, "value_text": "61", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Domestic Players Account for Most of China’s Approvals", "quote": "Notably, 61 drugs obtained their first global approval in China, their modalities ranging from small molecules and mAbs to vaccines, ADCs, cell and gene therapies, peptides, and fusion proteins.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_X2NWM2A19BHA2Q6D1FNAWTF9RG", "bibtex": "@misc{dia2025firstwtf9rg,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_X2NWM2A19BHA2Q6D1FNAWTF9RG},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_H6W4SX7J0V17KER005JG1VSH4N", "url": "https://statorigin.org/stat/stat_H6W4SX7J0V17KER005JG1VSH4N", "indicator": { "slug": "fusion-protein-approvals", "name": "Fusion protein approvals", "definition": "Total number of therapeutic fusion proteins granted regulatory marketing authorization." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 3, "value_text": "three", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Established Modalities Maintain a Larger Presence", "quote": "BsAbs and peptide therapies saw four new entrants each, while ADCs, cell therapies, and fusion proteins received three approvals each.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_H6W4SX7J0V17KER005JG1VSH4N", "bibtex": "@misc{dia2025fusion1vsh4n,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_H6W4SX7J0V17KER005JG1VSH4N},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_18CHCBGTNJTHCM0DT78MG2XQ1N", "url": "https://statorigin.org/stat/stat_18CHCBGTNJTHCM0DT78MG2XQ1N", "indicator": { "slug": "imported-drug-approvals", "name": "Imported drug approvals", "definition": "Total number of imported pharmaceutical products granted regulatory marketing approval." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 57, "value_text": "57", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Big Pharma Continues Betting on the Chinese Market", "quote": "Despite falling behind Chinese therapies for the first time, the number of imported drugs obtaining NMPA approval last year increased slightly to 57, a 48% share.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_18CHCBGTNJTHCM0DT78MG2XQ1N", "bibtex": "@misc{dia2025importedg2xq1n,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_18CHCBGTNJTHCM0DT78MG2XQ1N},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_D10K9QS3NSKSRKSDBD3PJZD8AK", "url": "https://statorigin.org/stat/stat_D10K9QS3NSKSRKSDBD3PJZD8AK", "indicator": { "slug": "imported-drug-share-of-approvals", "name": "Imported drug share of approvals", "definition": "Share of total approved new medicines accounted for by imported pharmaceutical products." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 48, "value_text": "48%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Big Pharma Continues Betting on the Chinese Market", "quote": "Despite falling behind Chinese therapies for the first time, the number of imported drugs obtaining NMPA approval last year increased slightly to 57, a 48% share.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_D10K9QS3NSKSRKSDBD3PJZD8AK", "bibtex": "@misc{dia2025importedjzd8ak,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_D10K9QS3NSKSRKSDBD3PJZD8AK},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_HVGAACMKGGATYT4MDH2BXJXAMY", "url": "https://statorigin.org/stat/stat_HVGAACMKGGATYT4MDH2BXJXAMY", "indicator": { "slug": "monoclonal-antibody-approvals", "name": "Monoclonal antibody approvals", "definition": "Total number of monoclonal antibody therapies authorized for commercial marketing." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 18, "value_text": "18", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Established Modalities Maintain a Larger Presence", "quote": "Similarly, mAbs claimed 15% of approvals (18 products) thanks to their long-validated technology.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_HVGAACMKGGATYT4MDH2BXJXAMY", "bibtex": "@misc{dia2025monoclonalxjxamy,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_HVGAACMKGGATYT4MDH2BXJXAMY},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_NM6AEQ3JF2DKFB7TD6GM0AV0T5", "url": "https://statorigin.org/stat/stat_NM6AEQ3JF2DKFB7TD6GM0AV0T5", "indicator": { "slug": "monoclonal-antibody-share-of-new-drug-approvals", "name": "Monoclonal antibody share of new drug approvals", "definition": "Percentage of total authorized new medicines accounted for by monoclonal antibody therapies." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 15, "value_text": "15%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Established Modalities Maintain a Larger Presence", "quote": "Similarly, mAbs claimed 15% of approvals (18 products) thanks to their long-validated technology.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_NM6AEQ3JF2DKFB7TD6GM0AV0T5", "bibtex": "@misc{dia2025monoclonal0av0t5,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_NM6AEQ3JF2DKFB7TD6GM0AV0T5},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_3C1JM05C6TBXGNX9X6NMFFXRET", "url": "https://statorigin.org/stat/stat_3C1JM05C6TBXGNX9X6NMFFXRET", "indicator": { "slug": "new-drug-approvals", "name": "New drug approvals", "definition": "Total number of new medicines granted regulatory marketing authorization for the first time." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 120, "value_text": "120", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "quote": "Excluding traditional Chinese medicines, the NMPA green-lit 120 new drugs, defined as those that obtained a marketing authorization in the country for the first time.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_3C1JM05C6TBXGNX9X6NMFFXRET", "bibtex": "@misc{dia2025drugffxret,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_3C1JM05C6TBXGNX9X6NMFFXRET},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_4ASFJ4Z25P4DR25ECVNYNZSFZJ", "url": "https://statorigin.org/stat/stat_4ASFJ4Z25P4DR25ECVNYNZSFZJ", "indicator": { "slug": "peptide-therapy-approvals", "name": "Peptide therapy approvals", "definition": "Total number of peptide therapeutic products authorized for commercial marketing." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 4, "value_text": "four", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Established Modalities Maintain a Larger Presence", "quote": "BsAbs and peptide therapies saw four new entrants each, while ADCs, cell therapies, and fusion proteins received three approvals each.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_4ASFJ4Z25P4DR25ECVNYNZSFZJ", "bibtex": "@misc{dia2025peptidenzsfzj,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_4ASFJ4Z25P4DR25ECVNYNZSFZJ},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_0NMTE9GQGBQQ1GZ7G06BVWRTFM", "url": "https://statorigin.org/stat/stat_0NMTE9GQGBQQ1GZ7G06BVWRTFM", "indicator": { "slug": "small-molecule-drug-approvals", "name": "Small molecule drug approvals", "definition": "Total number of small molecule drugs granted regulatory marketing authorization." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 72, "value_text": "72", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Established Modalities Maintain a Larger Presence", "quote": "As in previous years, in 2025, small molecules represented the mainstream of new drugs authorized by the NMPA, accounting for 60% of the total with 72 products.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_0NMTE9GQGBQQ1GZ7G06BVWRTFM", "bibtex": "@misc{dia2025smallvwrtfm,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_0NMTE9GQGBQQ1GZ7G06BVWRTFM},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_M57XGFPJYTE4DH5GRS653P29QP", "url": "https://statorigin.org/stat/stat_M57XGFPJYTE4DH5GRS653P29QP", "indicator": { "slug": "small-molecule-share-of-new-drug-approvals", "name": "Small molecule share of new drug approvals", "definition": "Percentage of total authorized new medicines accounted for by small molecule drugs." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 60, "value_text": "60%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "Established Modalities Maintain a Larger Presence", "quote": "As in previous years, in 2025, small molecules represented the mainstream of new drugs authorized by the NMPA, accounting for 60% of the total with 72 products.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_M57XGFPJYTE4DH5GRS653P29QP", "bibtex": "@misc{dia2025small3p29qp,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_M57XGFPJYTE4DH5GRS653P29QP},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" }, { "id": "stat_X8M04DZ4A1P892TV93P76ZFKA6", "url": "https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6", "indicator": { "slug": "type-2-diabetes-drug-launches", "name": "Type 2 diabetes drug launches", "definition": "Number of new pharmaceutical therapies launched or approved for the treatment of type 2 diabetes." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 6, "value_text": "six", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "DIA", "org_short_name": "DIA", "org_url": "https://www.diaglobal.org", "org_tier": 2, "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs", "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/", "document_type": "press_release", "locator": "The Cancer Sector Continues to Attract the Most Players", "quote": "Among them, six new drugs were launched for type 2 diabetes (T2D), including the DPP-4 inhibitor prusogliptin, the anti-CD3 biologic teplizumab, the GLP-1R agonist efsubaglutide α, as well as the combination therapies retagliptin + henagliflozin + metformin and retagliptin + metformin.", "published_date": null, "accessed_at": "2026-09-17", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T07:16:01.811Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6", "bibtex": "@misc{dia2025type6zfka6,\n author = {{DIA}},\n title = {2025 NMPA Approvals: China Clears Record Number of New Drugs},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6},\n note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.}\n}" }, "updated_at": "2026-09-17T07:16:01.811Z" } ] }, "meta": { "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.", "license": "https://creativecommons.org/licenses/by/4.0/", "docs": "https://statorigin.org/docs/api", "total": 20, "note": "Statistics are capped at 100 per request. Use /statistics?source_org=dia with a cursor to page through everything." } }